Functionalization of Nanosystems in Cancer Treatment

Bibliographic Details
Main Author: Luiz, Marcela Tavares
Publication Date: 2022
Other Authors: Dutra, Jessyca Aparecida Paes [UNESP], De Araújo, Jennifer Thayanne Cavalcante [UNESP], Di Filippo, Leonardo Delello [UNESP], Duarte, Jonatas Lobato [UNESP], Chorilli, Marlus [UNESP]
Format: Book part
Language: eng
Source: Repositório Institucional da UNESP
Download full: http://dx.doi.org/10.1007/978-3-031-17831-3_3
http://hdl.handle.net/11449/250008
Summary: Cancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization.
id UNSP_eab7b4ac842f664ca8d220660a7cc835
oai_identifier_str oai:repositorio.unesp.br:11449/250008
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Functionalization of Nanosystems in Cancer TreatmentActive targetingCarbodiimide chemistryClick chemistryMaleimide chemistryTargeting ligandsCancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization.School of Pharmaceutical Sciences of Ribeirao Preto University of Sao PauloSchool of pharmaceutical Sciences Sao Paulo State UniversitySchool of pharmaceutical Sciences Sao Paulo State UniversityUniversidade de São Paulo (USP)Universidade Estadual Paulista (UNESP)Luiz, Marcela TavaresDutra, Jessyca Aparecida Paes [UNESP]De Araújo, Jennifer Thayanne Cavalcante [UNESP]Di Filippo, Leonardo Delello [UNESP]Duarte, Jonatas Lobato [UNESP]Chorilli, Marlus [UNESP]2023-07-29T16:15:13Z2023-07-29T16:15:13Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bookPart71-101http://dx.doi.org/10.1007/978-3-031-17831-3_3Cancer Nanotechnology, p. 71-101.http://hdl.handle.net/11449/25000810.1007/978-3-031-17831-3_32-s2.0-85160483626Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCancer Nanotechnologyinfo:eu-repo/semantics/openAccess2025-03-29T05:19:45Zoai:repositorio.unesp.br:11449/250008Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-03-29T05:19:45Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Functionalization of Nanosystems in Cancer Treatment
title Functionalization of Nanosystems in Cancer Treatment
spellingShingle Functionalization of Nanosystems in Cancer Treatment
Luiz, Marcela Tavares
Active targeting
Carbodiimide chemistry
Click chemistry
Maleimide chemistry
Targeting ligands
title_short Functionalization of Nanosystems in Cancer Treatment
title_full Functionalization of Nanosystems in Cancer Treatment
title_fullStr Functionalization of Nanosystems in Cancer Treatment
title_full_unstemmed Functionalization of Nanosystems in Cancer Treatment
title_sort Functionalization of Nanosystems in Cancer Treatment
author Luiz, Marcela Tavares
author_facet Luiz, Marcela Tavares
Dutra, Jessyca Aparecida Paes [UNESP]
De Araújo, Jennifer Thayanne Cavalcante [UNESP]
Di Filippo, Leonardo Delello [UNESP]
Duarte, Jonatas Lobato [UNESP]
Chorilli, Marlus [UNESP]
author_role author
author2 Dutra, Jessyca Aparecida Paes [UNESP]
De Araújo, Jennifer Thayanne Cavalcante [UNESP]
Di Filippo, Leonardo Delello [UNESP]
Duarte, Jonatas Lobato [UNESP]
Chorilli, Marlus [UNESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Luiz, Marcela Tavares
Dutra, Jessyca Aparecida Paes [UNESP]
De Araújo, Jennifer Thayanne Cavalcante [UNESP]
Di Filippo, Leonardo Delello [UNESP]
Duarte, Jonatas Lobato [UNESP]
Chorilli, Marlus [UNESP]
dc.subject.por.fl_str_mv Active targeting
Carbodiimide chemistry
Click chemistry
Maleimide chemistry
Targeting ligands
topic Active targeting
Carbodiimide chemistry
Click chemistry
Maleimide chemistry
Targeting ligands
description Cancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
2023-07-29T16:15:13Z
2023-07-29T16:15:13Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bookPart
format bookPart
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1007/978-3-031-17831-3_3
Cancer Nanotechnology, p. 71-101.
http://hdl.handle.net/11449/250008
10.1007/978-3-031-17831-3_3
2-s2.0-85160483626
url http://dx.doi.org/10.1007/978-3-031-17831-3_3
http://hdl.handle.net/11449/250008
identifier_str_mv Cancer Nanotechnology, p. 71-101.
10.1007/978-3-031-17831-3_3
2-s2.0-85160483626
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Cancer Nanotechnology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 71-101
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1834482558612537344